Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 1,056 | 85 | 21 | 62 | 0 |
| Cost of Goods | 12 | 42 | 41 | N/A | N/A |
| Gross Profit | 1,044 | 43 | -20 | 62 | N/A |
| Operating Expenses | 6,583 | 4,079 | 4,329 | 3,694 | 20,839 |
| Operating Income | -5,527 | -3,994 | -4,308 | -3,632 | -20,839 |
| Interest Expense | 0 | 1 | 5 | 4 | 0 |
| Other Income | 0 | 0 | -2 | 0 | -4 |
| Pre-tax Income | -5,527 | -3,995 | -4,315 | -3,636 | -20,843 |
| Income Tax | -2,201 | -2,313 | -1,513 | -1,349 | N/A |
| Net Income Continuous | -3,326 | -1,682 | -2,802 | -2,287 | -17,562 |
| Net Income | $-3,326 | $-1,682 | $-2,802 | $-2,287 | $-17,562 |
| EPS Basic Total Ops | -0.12 | -0.05 | -0.09 | -0.07 | 90.30 |
| EPS Basic Continuous Ops | -0.11 | -0.05 | -0.09 | -0.08 | 90.21 |
| EPS Diluted Total Ops | -0.12 | -0.05 | -0.09 | -0.07 | 90.30 |
| EPS Diluted Continuous Ops | -0.11 | -0.05 | -0.09 | -0.08 | 90.21 |
| EBITDA(a) | $-2,707 | $-3,130 | $-3,465 | $-2,755 | $-19,903 |